跳至主要内容
临床试验/NCT00186771
NCT00186771Unknown4 期

Transcranial Magnetic Stimulation Used to Treat Auditory Hallucinations in Schizophrenia

St. Joseph's Healthcare Hamilton2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2004年11月最近更新:
适应症

试验速览

阶段
4 期
入组人数
10
试验地点
2
主要终点
Hoffman Auditory Hallucination Scale

研究概览

简要总结

Schizophrenia is a chronic, severe, and disabling brain disease. Auditory hallucinations are the most frequent symptoms with an incident of 50% to 70% in patients.

Transcranial Magnetic Stimulation (TMS) can significantly reduce symptoms of schizophrenia. TMS is capable of inducing changes in the electrical activities of the brain in humans.

The purpose of this trial is to study the use of TMS to decrease auditory hallucinations in schizophrenia.

详细描述

We hypothesize that: True treatment with rTMS will have significant decrease in auditory hallucinations versus sham treatment over the temporoparietal cortex.

FMRI will highlight areas of activation with auditory hallucinations distinct from the area identified by Hoffman's scalp based method.

Cortical inhibition as measured by paired pulse TMS will be increased after true TMS but not sham TMS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Schizophrenia
  • Auditory hallucinations occuring more than 5 times per day
  • Adequate (6 weeks) trial of antipsychotic medication
  • Including at least 1 atypical antipsychotic medication
  • Medication stable for 4 weeks prior to commencement of the study
  • Competent to consent

排除标准

  • history of seizure disorder in patient or first degree relative
  • recent head injury
  • Acute suicidality
  • Alcohol or substance abuse
  • Implanted pacemaker or metal in head or neck
  • Pregnancy

结局指标

主要结局

Hoffman Auditory Hallucination Scale

时间窗: weekly

A series of 7 questions to identify the intensity and severity of the hallucinations

次要结局

  • Positive and Negative Syndrome Scale for Schizophrenia (PANSS)(2 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验